Skip to main navigation Skip to search Skip to main content

Investigating the role of exosomes and the cell fate regulator, ASCL1 in driving, and maintaining lethal Neuroendocrine transdifferentiation of prostate cancer

Project Details

StatusFinished
Effective start/end date1/04/21 → 31/05/24

Funding

  • Melville Trust for Care and Cure of Cancer: £87,733.48